Understanding Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN)

Receiving a diagnosis of Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN) often marks the end of a long and exhausting search for answers—a “diagnostic odyssey” that many families of children with rare conditions describe as isolating and overwhelming ^[1][2]. It is common to feel a mix of relief at finally having a name for the symptoms, alongside profound grief and fear about the future ^[3]. FAHN is an ultra-rare condition, meaning your local doctor may never have seen a case before ^[4]. Because it is so rare, you may find yourself becoming the leading expert on your child’s specific needs while working with specialists to coordinate their care ^[1].

What is FAHN?

FAHN is a genetic condition caused by changes (variants) in the FA2H gene ^[5]. This gene is responsible for producing an enzyme that helps create specific fats (lipids) essential for the health of the nervous system ^[5]. Because FA2H-related disease exists on a spectrum and affects several different systems in the brain, doctors use overlapping names to describe it:

• FAHN: Usually used when the focus is on the way the disease progresses and affects the brain’s movement centers and iron accumulation ^[6].
• SPG35: Short for spastic paraplegia type 35, used when the primary presentation is spasticity (muscle stiffness and tightness) in the legs ^[7]. These are not separate diseases; they refer to the same FA2H genetic spectrum.
• Leukodystrophy: A general term for diseases that affect the myelin, the protective insulation around nerve fibers ^[5].

FAHN is an autosomal recessive condition. This means a child must inherit one changed copy of the gene from each parent to be affected ^[8].

Understanding Recurrence Risk
If both biological parents are confirmed to be carriers of an FA2H variant, each future pregnancy has a:

• 25% chance of inheriting both variants and having the condition.
• 50% chance of inheriting one variant, making the child a carrier (like the parents).
• 25% chance of inheriting neither variant.
  Families should consult a genetic counselor to discuss testing options for siblings and relatives.

While FAHN is exceptionally rare and its exact prevalence is not well established, modern genetic testing is helping more families find answers sooner ^[4][9].

The Role of Myelin and Iron

The FA2H gene plays a critical role in maintaining myelin ^[10]. Without the proper fats, the myelin can become unstable or break down, which disrupts how the brain sends signals to the rest of the body ^[11]. This is why FAHN is considered a type of leukodystrophy ^[5].

FAHN is also classified as a type of Neurodegeneration with Brain Iron Accumulation (NBIA) ^[5]. In some individuals with this condition, iron begins to build up in specific parts of the brain, such as the globus pallidus ^[5]. However, it is important to know that iron accumulation is not always present, especially in the early stages ^[12]. In some reported cases, patients have been followed for over a decade without showing any iron buildup on an MRI ^[13]. The absence of iron does not exclude the diagnosis if the genetic testing and clinical picture are clear ^[14].

What to Expect in Early Childhood

FAHN typically begins in early childhood ^[5]. While every child’s journey is unique, the condition is progressive, meaning symptoms tend to change and become more pronounced over time ^[15].

Common early signs include:

• Spasticity: Stiffness in the legs that can make walking difficult ^[5].
• Ataxia: Problems with balance and coordination, often appearing as “clumsiness” or truncal instability ^[15].
• Dysarthria: Changes in speech, which may become slurred or difficult to understand ^[5].
• Cognitive Changes: Difficulties with learning or processing information ^[5].

The speed of progression varies substantially. In one small study of 19 individuals with FAHN, the median time from the first symptoms to the loss of independent walking was about 7 years ^[5]. However, this is a population observation from a limited cohort, not a prediction of your child’s individual course. Progression can be slower or faster, and planning is individualized based on your child’s specific needs.

Navigating the Emotional Journey

Parenting a child with a progressive rare disease brings a unique set of challenges. Research shows that parents of children with leukodystrophies often experience high levels of stress and a heavy “caregiver burden” ^[16]. It is common to feel a sense of “anticipatory grief” as you navigate the loss of abilities your child once had ^[3].

You may find that you have to educate your own medical team. Finding a multidisciplinary team—including neurologists, physical therapists, and genetic counselors—is essential for managing symptoms and maintaining your child’s comfort ^[17][18]. Remember that seeking support for yourself through counseling or peer groups is not a sign of weakness, but a necessary part of sustaining the long-term care your child needs ^[16][1].

While there is currently no cure, management focuses on symptomatic care: addressing muscle stiffness, ensuring safe nutrition if swallowing becomes difficult, and using therapy to maximize your child’s independence, comfort, and quality of life for as long as possible ^[19][17].